EFFECTS OF GARLIC POWDER ON GLYCEMIC CONTROL IN THE PATIENTS OF TYPE-2 DIABETES MELLITUS
Main Article Content
Keywords
Type-2 Diabetes Mellitus, Garlic Powder, Glycemic Index
Abstract
Diabetes Mellitus is one of the most common health hazards in the world, especially in the South Asian region, with 9.2% of the Pakistani population suffering from type-2 diabetes mellitus. This can lead to many complications if glycemic control is not properly monitored. Garlic is one natural product containing sulphur compounds that act as hypoglycemic agents.
Objective: To evaluate the effects of Garlic powder on glycemic index in the patients of type-2diabetes along with allopathic therapy.
Methodology: This RCT includes 80 patients divided into 2 groups. Each group included 40 diagnosed cases of type-2 diabetes. Patients in Group A were taking only oral hypoglycemic drugs, while patients in Group B were receiving formulated capsules of garlic powder along with oral hypoglycemic drugs for six months. Blood samples were taken at zero level, level-I, and level-II for analysis of fasting and random blood glucose levels and HbA1C.
Results: The outcomes of garlic therapy were observed, and there was significantly (p < 0.05) good glycemic control with garlic therapy as compared with allopathic therapy alone.
Conclusion: The results concluded that there was a marvellous role for natural remedies like garlic powder in conjunction with allopathic therapy in the management of type-2 diabetic patients with a satisfactory glycemic index.
References
2. Liu J, Ren ZH, Qiang H, Wu J, Shen M, Zhang L, Lyu J. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC public health. 2020 Dec;20(1):1-2.
3. Morton JI, Liew D, McDonald SP, Shaw JE, Magliano DJ. The association between age of onset of type 2 diabetes and the long-term risk of end-stage kidney disease: a national registry study. Diabetes Care. 2020 Aug 1;43(8):1788-95.
4. Sazlina SG, Lee PY, Chan YM, A. Hamid MS, Tan NC. The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia. PloS one. 2020 May 20;15(5):e0233299.
5. de Alba IG, Gimeno-Miguel A, Poblador-Plou B, Gimeno-Feliu LA, Ioakeim-Skoufa I, Rojo-Martínez G, Forjaz MJ, Prados-Torres A. Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients. Scientific reports. 2020 Nov 11;10(1):1-9.
6. Rathi J, Kumar S, Kumari B, Khansili A, Narwal S, Purohit D, Manchanda D, Makhija M, Saini S, Pandey P. Role of Herbal Medicines in the Treatment of Diabetes Mellitus: An Updated Review. Annals of the Romanian Society for Cell Biology. 2021 Jun 23;25(6):13190-9.
7. Narayan KV, Kanaya AM. Why are South Asians prone to type 2 diabetes? A hypothesis based on underexplored pathways. Diabetologia. 2020 Jun;63(6):1103-9.
8. Rouf R, Uddin SJ, Sarker DK, Islam MT, Ali ES, Shilpi JA, Nahar L, Tiralongo E, Sarker SD. Anti-viral potential of garlic (Allium sativum) and it's organosulfur compounds: a systematic update of pre-clinical and clinical data. Trends in food science & technology. 2020 Aug 19.
9. Sarıyıldız T. Effects of leonardite and mineral fertilizer applications on plant growth and soil quality of garlic (Allium sativum L.). Turkish Journal of Agriculture-Food Science and Technology. 2020 Aug 30;8(8):1763-72.
10. El-Saber Batiha G, MagdyBeshbishy A, G Wasef L, Elewa YH, A Al-Sagan A, El-Hack A, Mohamed E, Taha AE, M Abd-Elhakim Y, Prasad Devkota H. Chemical constituents and pharmacological activities of garlic (Allium sativum L.): A review. Nutrients. 2020 Mar;12(3):872.
11. Nasir A, Fatma G, Neshat N, Ahmad MA. Pharmacological and therapeutic attributes of garlic (Allium sativum Linn.) with special reference to Unani medicine—A review. J. Med. Plants Stud. 2020;8:6-9.
12. Tavares L, Santos L, Noreña CP. Bioactive compounds of garlic: A comprehensive review of encapsulation technologies, characterization of the encapsulated garlic compounds and their industrial applicability. Trends in Food Science & Technology. 2021 May 27.
13. Janská P, Knejzlík Z, Perumal AS, Jurok R, Tokárová V, Nicolau DV, Štěpánek F, Kašpar O. Effect of physicochemical parameters on the stability and activity of garlic alliinase and its use for in-situ allicin synthesis. Plos one. 2021 Mar 19;16(3):e0248878.
14. Tazikeh T, AbedianKenari A, Esmaeili M. Effects of fish meal replacement by meat and bone meal supplemented with garlic (Allium sativum) powder on biological indices, feeding, muscle composition, fatty acid and amino acid profiles of whiteleg shrimp (Litopenaeusvannamei). Aquaculture Research. 2020 Feb;51(2):674-86.
15. Attia KM, Assar MH, Farouk ZM, Basuney HA. Possible Protective Effects of Black Seed (Nigella Sativa) or Garlic (Allium Sativum) Against Lead-Induced Toxicity in growing rabbits. Alexandria Journal for Veterinary Sciences. 2020 Apr 1;64(2).
16. Yousef EA, Elsadek MA. A Comparative study of morphological and volatile oil composition characteristics in diploid and tetraploid garlic plants. Egyptian Journal of Horticulture. 2020 Apr 1;47(1):1-4.
17. Faisal AN. The Role of Allicin in Regulating Insulin and Glycemic Level in White Mice with Induced Insulin Resistance. Annals of the Romanian Society for Cell Biology. 2021 Apr 25:10921-8.
18. Sobenin IA, Nedosugova LV, Filatova LV, et al. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo controlled study. Acta Diabetol. 2008;45(1):1–6.
19. Ashraf R, Khan RA, Ashraf I. Garlic (Allium sativum)supplementation with standard antidiabetic agent providesbetter diabetic control in type 2 diabetes patients.Pak J Pharm Sci. 2011;24(4):565–570.
20. Ebadi A, RahimiLenji A, Taghadosi M, Khorshidi A,Akbari H. The effect of garlic pills on blood glucose in type2 diabetic patients. Feyz Scientific-Research Quarterly,2007; 11 (1): 20-25.
21. Khademian R, Mozafari H, Esteghamati A, Pasha Meisami A. Study of the effect of taking blood glucosetablets and lipid profile in patients with type 2 diabetesis an unannounced randomized clinical trial. Journal of Shaheed Sadoughi University of Medical Sciences Yazd,2016; 22(7): 621-630.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.